Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inhibitors of growth factor receptor tyrosine kinases developed at BMS

Jan. 15, 2001

Sonus begins phase I evaluation of less toxic form of paclitaxel

Jan. 15, 2001

Sanofi-Synthelabo to market Leuprogel in the U.S. and Canada

Jan. 12, 2001

NCI and Biovest may enter B-cell lymphoma vaccine collaboration

Jan. 12, 2001

Preparation and use of cyclin-dependent kinase inhibitors

Jan. 11, 2001

Novel series from Pfizer for use in hyperproliferative conditions

Jan. 11, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Ilex submits IND to FDA for angiogenesis inhibitor NM-3

Jan. 11, 2001

AVI BioPharma receives grant to develop NeuGene-based prostate cancer therapeutics

Jan. 10, 2001

Major functional genomics collaboration in oncology formed in Europe

Jan. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...